PMI: FY23 Results

Key Business Metrics: Q4 20231 Revenue: up +8.3% to $9Bn (vs. $9Bn expected) Adjusted diluted EPS: up +12.2% to $1.36 (vs. $1.45 expected) Total volume: down -0.5% to 185.1Bn (HnB volume: +6.1% to 34Bn) Oral nicotine shipment volume: +23.4% to 219.6Mn cans Smoke-free revenue: up +13.6% to $3.6Bn => 39.3%...

BAT: FY23 Results

Top-line1 - Revenue: £27.28Bn (vs. £27.9Bn expected) - Reported Revenue: down -1.3%, largely due to the sale of Russian business as well as the impact of lower cigarette volume (mainly in the US) and a translational FX headwind of 2.9% (due to the relative strength of £, particularly against the...

Call Request:
Reports

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address
Disclaimer: The content in our Market Pulse section is/shall not be construed as investment advice. It is for informative purposes only and does not take into account the individual needs, investment objectives and specific financial circumstances. Any action taken upon the information in our Market Pulse section is strictly at the reader’s own risk. We assume no responsibility or liability for the actions taken. Moreover, we also assume no responsibility or liability for any errors or omissions in our content – which is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness even if we only depend on the infromation sources that are believed to be accurate.

Consultation
Session Request

We will reach out to you within 24 hours to discuss your request. Please note that we only respond to requests with a valid business e-mail address